Related Experiment Video
Updated: Sep 21, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Insights
Elevated cyclic AMP inhibits NF-kappaB transcription by activating protein kinase A. This pathway phosphorylates CREB, which then competes with NF-kappaB p65 for the coactivator CBP, thus blocking gene expression.
Area of Science:
- Molecular Biology
- Cell Signaling
- Gene Regulation
Background:
- NF-kappaB transcription factors control inducible gene expression.
- Elevated cyclic AMP (cAMP) inhibits NF-kappaB transcription in monocytes and endothelial cells without affecting nuclear translocation.
- The molecular mechanisms underlying cAMP-mediated inhibition of NF-kappaB are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanism by which elevated intracellular cAMP inhibits NF-kappaB-mediated transcription.
- To determine if protein kinase A (PKA) activation and subsequent CREB phosphorylation play a role in this inhibition by competing for the coactivator CBP.
Main Methods:
- In vitro and in vivo interaction studies between CBP and NF-kappaB p65 (RelA).
- Functional studies in human endothelial cells using overexpression of CBP and CREB.
- Assays to measure NF-kappaB-mediated transcription and transcription mediated by a GAL4-p65 fusion protein.
Main Results:
- The N-terminal region of CBP (amino acids 1-450) specifically interacts with the C-terminal region of NF-kappaB p65 (amino acids 286-551).
- Overexpression of CBP rescued cAMP-induced inhibition of NF-kappaB transcription and transcription mediated by GAL4-p65(286-551).
- Overexpression of CREB inhibited GAL4-p65(286-551)-mediated transcription, suggesting competition for CBP.
Conclusions:
- Activation of the PKA pathway inhibits NF-kappaB transcription.
- This inhibition occurs because PKA phosphorylates CREB, which then competes with NF-kappaB p65 for binding to the limiting coactivator CBP.
- This mechanism explains how cAMP signaling modulates NF-kappaB-dependent gene expression.
Abstract:
The NF-kappaB family of transcription factors regulates the inducible expression of a variety of genes. Recently, we showed that elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytes and endothelial cells without preventing nuclear translocation of NF-kappaB complexes. The present study examined the molecular mechanism of this inhibition. We hypothesized that activation of the protein kinase A signaling pathway may inhibit NF-kappaB-mediated transcription by phosphorylating proteins, such as cAMP response element-binding protein (CREB), which compete for limiting amounts of the coactivator CBP. Here, we show that the amino-terminal region (amino acids 1-450) of CBP specifically interacts with the carboxyl-terminal region (amino acids 286-551) of NF-kappaB p65 (RelA) both in vitro and in vivo. Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF-kappaB-mediated transcription and transcription mediated by a chimeric protein, GAL4-p65(286-551), which contained the GAL4 DNA binding domain fused to the carboxyl-terminal region of p65 (amino acids 286-551). In contrast, overexpression of CREB inhibited GAL4-p65(286-551)-mediated transcription. These results suggest that activation of the protein kinase A pathway inhibits NF-kappaB transcription by phosphorylating CREB, which competes with p65 for limiting amounts of CBP.
More Related Videos
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

